Loading...
Chemed Corporation
CHE•NYSE
Healthcare
Medical - Care Facilities
$470.72
$7.70(1.66%)
Chemed Corporation (CHE) Financial Performance & Income Statement Overview
Review Chemed Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
7.37%
↑ 7.37%
Operating Income Growth
7.61%
↑ 7.61%
Net Income Growth
10.82%
↑ 10.82%
Operating Cash Flow Growth
26.40%
↑ 26.40%
Operating Margin
15.63%
↑ 15.63%
Gross Margin
33.54%
↑ 33.54%
Net Profit Margin
12.40%
↑ 12.40%
ROE
26.03%
↑ 26.03%
ROIC
27.08%
↑ 27.08%
Chemed Corporation (CHE) Income Statement & Financial Overview
Review Chemed Corporation's (CHE) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $646.94M | $639.99M | $606.18M | $595.88M |
| Cost of Revenue | $446.55M | $405.88M | $396.19M | $405.46M |
| Gross Profit | $200.40M | $234.12M | $209.99M | $190.42M |
| Gross Profit Ratio | $0.31 | $0.37 | $0.35 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $105.59M | $104.25M | $101.98M | $102.25M |
| Operating Expenses | $121.66M | $120.24M | $117.84M | $102.29M |
| Total Costs & Expenses | $552.18M | $526.12M | $514.02M | $507.75M |
| Interest Income | $0.00 | $3.21M | $3.67M | $3.50M |
| Interest Expense | $0.00 | $499000.00 | $427000.00 | $429000.00 |
| Depreciation & Amortization | -$587000.00 | $15.83M | $15.70M | $15.71M |
| EBITDA | $94.76M | $136.45M | $117.15M | $103.84M |
| EBITDA Ratio | $0.15 | $0.21 | $0.19 | $0.17 |
| Operating Income | $94.76M | $113.88M | $92.16M | $88.13M |
| Operating Income Ratio | $0.15 | $0.18 | $0.15 | $0.15 |
| Other Income/Expenses (Net) | $916000.00 | $6.25M | $8.87M | $5.70M |
| Income Before Tax | $95.67M | $120.12M | $101.03M | $93.83M |
| Income Before Tax Ratio | $0.15 | $0.19 | $0.17 | $0.16 |
| Income Tax Expense | $23.92M | $29.80M | $25.25M | $22.94M |
| Net Income | $71.76M | $90.32M | $75.78M | $70.89M |
| Net Income Ratio | $0.11 | $0.14 | $0.13 | $0.12 |
| EPS | $4.91 | $6.08 | $5.04 | $4.70 |
| Diluted EPS | $4.86 | $6.02 | $5.02 | $4.65 |
| Weighted Avg Shares Outstanding | $14.62M | $14.85M | $15.03M | $15.10M |
| Weighted Avg Shares Outstanding (Diluted) | $14.76M | $14.99M | $15.08M | $15.25M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan